HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation

2014/02/01 by Elizabeth D Mellins, Lawrence J Stern · 1 citation

paper · doi:10.1016/j.coi.2013.11.005

Cited by

• Nonclassical MHC‐I Molecules: Emerging Therapeutic Targets in Next‐Generation Immunotherapy